{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:13:41Z","timestamp":1773324821825,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T00:00:00Z","timestamp":1529971200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s12185-018-2485-4","type":"journal-article","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T07:27:55Z","timestamp":1529998075000},"page":"554-557","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Successful treatment of cytarabine-related neurotoxicity with corticosteroids, a case series"],"prefix":"10.1007","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6193-3179","authenticated-orcid":false,"given":"Jennifer L.","family":"Dotson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Omer","family":"Jamil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,26]]},"reference":[{"issue":"6","key":"2485_CR1","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1200\/JCO.1987.5.6.927","volume":"5","author":"RH Herzig","year":"1987","unstructured":"Herzig RH, Hines JD, Herzig GP, Wolff SN, Cassileth PA, Lazarus HM, et al. Cerebellar toxicity with high-dose cytosine arabinoside. J Clin Oncol. 1987;5(6):927\u201332.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2485_CR2","doi-asserted-by":"publisher","first-page":";7","DOI":"10.2165\/00002018-199005010-00003","volume":"5","author":"J Stentoft","year":"1990","unstructured":"Stentoft J. The toxicity of cytarabine. Drug Saf. 1990;5(1):;7\u201327.","journal-title":"Drug Saf"},{"issue":"14","key":"2485_CR3","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJM199410063311402","volume":"331","author":"RJ Mayer","year":"1994","unstructured":"Mayer RJ, Davis RB, Schiffer CA, Berg DT, Powell BL, Schulman P, et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia. NEJM. 1994;331(14):896.","journal-title":"NEJM"},{"issue":"2","key":"2485_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nrclinonc.2015.152","volume":"13","author":"JB Stone","year":"2016","unstructured":"Stone JB, DeAngelis LM. Cancer treatment-induced neurotoxicity: a focus on newer treatments. Nature Rev Clin Oncol. 2016;13(2):92\u2013105.","journal-title":"Nature Rev Clin Oncol"},{"key":"2485_CR5","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/1097-0142(19830201)51:3<426::AID-CNCR2820510312>3.0.CO;2-S","volume":"51","author":"MC Salinsky","year":"1983","unstructured":"Salinsky MC, Levine RL, Aubuchon JP, Schutta HS. Acute cerebellar dysfunction with high-dose ARA-C therapy. Cancer. 1983;51:426\u20139.","journal-title":"Cancer"},{"issue":"3","key":"2485_CR6","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/mds.1098","volume":"16","author":"JH Friedman","year":"2001","unstructured":"Friedman JH, Shetty N. Permanent cerebellar toxicity of cytosine arabinoside (Ara C) in a young woman. Mov Disord. 2001;16(3):575.","journal-title":"Mov Disord"},{"key":"2485_CR7","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1002\/1097-0142(19811215)48:12<2577::AID-CNCR2820481207>3.0.CO;2-Z","volume":"48","author":"HM Lazarus","year":"1981","unstructured":"Lazarus HM, Herzig RH, Fishman DJ, Herzig GP, Phillips GL, Roessmann U. Central nervous system toxicity of high-dose systemic cytosine arabinoside. Cancer. 1981;48:2577\u201382.","journal-title":"Cancer"},{"key":"2485_CR8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s12185-008-0171-7","volume":"88","author":"LH Lindner","year":"2008","unstructured":"Lindner LH, Ostermann H, Hiddemann W, Kiana A, Wurfel M, et al. AraU accumulation in patients with renal insufficiency as a potential mechanism for cytarabine neurotoxicity. Int J Hematol. 2008;88:381\u201386.","journal-title":"Int J Hematol"},{"issue":"4","key":"2485_CR9","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1200\/JCO.1991.9.4.679","volume":"9","author":"WJ Baker","year":"1991","unstructured":"Baker WJ, Royer GL Jr, Weiss RB. Cytarabine and neurologic toxicity. J Clin Onc. 1991;9(4):679\u201393.","journal-title":"J Clin Onc"},{"key":"2485_CR10","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/ajh.20171","volume":"77","author":"P Malhotra","year":"2004","unstructured":"Malhotra P, Mahi S, Lal V, Kumari S, Jain S, Varma S. Cytarabine-induced neurotoxicity responding to methyl prednisolone. Am J Hematol. 2004;77:416\u201322.","journal-title":"Am J Hematol"},{"key":"2485_CR11","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1002\/(SICI)1097-0142(19961101)78:9<1899::AID-CNCR9>3.0.CO;2-A","volume":"78","author":"H Openshaw","year":"1996","unstructured":"Openshaw H, Slatkin NE, Stein AS, Hinton DR, Forman SJ. Acute polyneuropathy after high dose cytosine arabinoside in patients with leukemia. Cancer. 1996;78:1899\u2013905.","journal-title":"Cancer"},{"issue":"10","key":"2485_CR12","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1182\/blood-2012-04-424440","volume":"120","author":"T Zuckerman","year":"2012","unstructured":"Zuckerman T, Ganzel C, Tallman MS, Rowe JM. How I treat hematologic emergencies in adults with acute leukemia. Blood. 2012;120(10):1993\u20132002.","journal-title":"Blood"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-018-2485-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-018-2485-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-018-2485-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T19:32:51Z","timestamp":1561491171000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-018-2485-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,26]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["2485"],"URL":"https:\/\/doi.org\/10.1007\/s12185-018-2485-4","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,26]]},"assertion":[{"value":"9 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}